These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 11391686

  • 1. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
    Smith PC, Keller ET.
    Prostate; 2001 Jun 15; 48(1):47-53. PubMed ID: 11391686
    [Abstract] [Full Text] [Related]

  • 2. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
    Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET.
    Cancer Res; 2006 Mar 15; 66(6):3087-95. PubMed ID: 16540658
    [Abstract] [Full Text] [Related]

  • 4. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N, Belldegrun A, Bonavida B.
    Cancer Res; 1995 Oct 15; 55(20):4633-9. PubMed ID: 7553641
    [Abstract] [Full Text] [Related]

  • 5. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.
    Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439
    [Abstract] [Full Text] [Related]

  • 6. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
    Evans S, Dizeyi N, Abrahamsson PA, Persson J.
    Anticancer Res; 2009 Oct 01; 29(10):3917-24. PubMed ID: 19846929
    [Abstract] [Full Text] [Related]

  • 7. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
    Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG.
    Clin Cancer Res; 1998 Aug 01; 4(8):2009-14. PubMed ID: 9717832
    [Abstract] [Full Text] [Related]

  • 8. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P, Chatterjee D, Wyche J, DeJesus A, Early J, Plaschke S, Giovanella B.
    J Exp Ther Oncol; 1996 Sep 01; 1(5):322-33. PubMed ID: 9414421
    [Abstract] [Full Text] [Related]

  • 9. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 Oct 01; 24(10):1665-70. PubMed ID: 12896904
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
    Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I.
    Apoptosis; 2006 Jan 01; 11(1):89-99. PubMed ID: 16374544
    [Abstract] [Full Text] [Related]

  • 11. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 12. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J.
    Clin Cancer Res; 2006 Feb 15; 12(4):1292-8. PubMed ID: 16489086
    [Abstract] [Full Text] [Related]

  • 13. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 14. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
    Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Rubio J, Tekyi-Mensah S, Layer A, Che M, Forman JD.
    Clin Cancer Res; 2001 Jan 15; 7(1):136-44. PubMed ID: 11205901
    [Abstract] [Full Text] [Related]

  • 15. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H.
    Cancer Res; 2005 Dec 01; 65(23):11203-13. PubMed ID: 16322271
    [Abstract] [Full Text] [Related]

  • 16. Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
    Steiner H, Cavarretta IT, Moser PL, Berger AP, Bektic J, Dietrich H, Zaki MH, Nakada M, Hobisch A, Nemeth JA, Culig Z.
    Prostate; 2006 Dec 01; 66(16):1744-52. PubMed ID: 16998813
    [Abstract] [Full Text] [Related]

  • 17. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies.
    Li L, Zhu Z, Joshi B, Zhang C, Johnson CR, Marnett LJ, Honn KV, Crissman JD, Porter AT, Tang DG.
    Anticancer Res; 1999 Dec 01; 19(1A):61-9. PubMed ID: 10226525
    [Abstract] [Full Text] [Related]

  • 18. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 01; 12(9):933-9. PubMed ID: 14504208
    [Abstract] [Full Text] [Related]

  • 19. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 01; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 20. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.